Human Endogenous Retrovirus-H Long Terminal Repeat-Associating Protein 2 (HHLA2) is a Novel Immune Checkpoint Protein in Lung Cancer which Predicts Survival

BACKGROUND: Lung cancer is one of the most frequently diagnosed malignancies. Human endogenous retrovirus-H long terminal repeat-associating protein 2 (HHLA2) is a recently discovered ligand of the B7 family. Blocking this immune checkpoint has become an important treatment option for lung cancer. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Farrag, Mayada Saad, Ibrahim, Eman Mohamad, El-Hadidy, Tamer A, Akl, Mohamed Farouk, Elsergany, Alyaa R, Abdelwahab, Heba Wagih
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418860/
https://www.ncbi.nlm.nih.gov/pubmed/34181347
http://dx.doi.org/10.31557/APJCP.2021.22.6.1883

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418860/
https://www.ncbi.nlm.nih.gov/pubmed/34181347
http://dx.doi.org/10.31557/APJCP.2021.22.6.1883

Ejemplares similares